US Pharmas Display Defensive Mettle But Headwinds Mount

 
• By Jessica Merrill

US big pharma manufacturers generally delivered sales and earnings growth in the second quarter and reaffirmed guidance despite currency headwinds; US drug pricing legislation could present a tipping pressure point.  

Money Boat
• Source: Shutterstock

More from Growth

More from In Vivo